-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 15th, Sinopharm Hyundai issued an announcement stating that its holding subsidiary Sinopharm Yixin recently received the "Approval Notice for Supplementary Drug Application" for Octreotide Acetate Injection approved and issued by the National Medical Products Administration, approving the drug to pass the generic drug consistency Evaluation
Octreotide acetate is a synthetic octapeptide compound that can inhibit the response of luteinizing hormone to gonadotropin releasing hormone, reduce visceral blood flow, inhibit serotonin, gastrin, vasoactive intestinal peptide, chymotrypsin, and motilin , The secretion of glucagon